ICC
Icecure Medical
Stock
Stock
ISIN: IL0011224156
Ticker: ICCM
IL0011224156
ICCM
Price
Price
CHART BY
Frequently asked questions
What is Icecure Medical's market capitalization?
The market capitalization of Icecure Medical is $61.35M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Icecure Medical?
Icecure Medical's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.286. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Icecure Medical's stock?
Currently, 3 analysts cover Icecure Medical's stock, with a consensus target price of $3.367. Analyst ratings provide insights into the stock's expected performance.
What is Icecure Medical's revenue over the trailing twelve months?
Over the trailing twelve months, Icecure Medical reported a revenue of $3.67M.
What is the EBITDA for Icecure Medical?
Icecure Medical's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$14.25M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Icecure Medical?
Icecure Medical has a free cash flow of -$10.99M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Icecure Medical have, and what sector and industry does it belong to?
Icecure Medical employs approximately 77 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Icecure Medical's shares?
The free float of Icecure Medical is 24.40M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $61.35M
- EPS (TTM)
- -$0.286
- Free Float
- 24.40M
- Revenue (TTM)
- $3.67M
- EBITDA (TTM)
- -$14.25M
- Free Cashflow (TTM)
- -$10.99M
Pricing
- 52W span
- $0.48$1.56
Analyst Ratings
The price target is $3.367 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
- Employees
- 77
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- IL0011224156
- Primary Ticker
- ICCM